approved

Приложение 4 на ПЛС от 02.11.2019 г.

Unique identificator:  9bc14123-eddd-4804-993b-4d554402e443

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-11-11 16:52:26
  • Created by: georgi_sivchev
  • Updated at: 2019-11-11 16:52:26
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Methoxy polyethylene glycol-epoetin beta EU/1/07/400/009 Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration GmbH, Германия Roche Pharma AG, Germany 212.72 42.54 255.26 4% 8.51 221.23 44.25 265.48 16% 25 246.23 49.25 295.48 Промяна на обстоятелствата НСР-15751/25.05.2018. НСР-3305/24.04.2014; НСР-9708/07.07.2016; НСР-14021/02.10.2017; НСР-15825/08.06.2018 23.06.2018 02.07.2018 Неактивен 2719
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration GmbH, Германия Roche Pharma AG, Germany 425.18 85.04 510.22 4% 10 435.18 87.04 522.22 16% 25 460.18 92.04 552.22 Промяна на обстоятелствата НСР-15748/25.05.2018. НСР-3302/24.04.2014; НСР-9709/07.07.2016; НСР-14020/02.10.2017; НСР-15826/08.06.2018 23.06.2018 02.07.2018 Неактивен 2721
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/010 Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration GmbH, Германия Roche Pharma AG, Germany 283.61 56.72 340.33 4% 10 293.61 58.72 352.33 16% 25 318.61 63.72 382.33 Промяна на обстоятелствата НСР-15750/25.05.2018. НСР-3304/24.04.2014; НСР-9707/07.07.2016; НСР-15199/09.03.2018 24.03.2018 02.07.2018 Неактивен 2720
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 Mircera, Solution for injection, 50 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration GmbH, Германия Roche Pharma AG, Germany 143.38 28.68 172.06 4% 5.74 149.12 29.82 178.94 16% 22.94 172.06 34.41 206.47 Промяна на обстоятелствата НСР-15749/25.05.2018. НСР-4286/05.08.2014; НСР-10453/29.09.2016; НСР-14667/20.12.2017 06.01.2018 02.07.2018 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 428.35 85.67 514.02 4% 10 438.35 87.67 526.02 16% 25 463.35 92.67 556.02 НСР-3302/24.04.2014; НСР-9709/07.07.2016; НСР-14020/02.10.2017 17.10.2017 02.11.2017 Неактивен 2721
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 Mircera, Solution for injection, 50 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 143.38 28.68 172.06 4% 5.74 149.12 29.82 178.94 16% 22.94 172.06 34.41 206.47 НСР-4286/05.08.2014; НСР-10453/29.09.2016; НСР-14667/20.12.2017 06.01.2018 02.02.2018 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/010 Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 283.61 56.72 340.33 4% 10 293.61 58.72 352.33 16% 25 318.61 63.72 382.33 НСР-3304/24.04.2014; НСР-9707/07.07.2016; НСР-15199/09.03.2018 24.03.2018 02.04.2018 Неактивен 2720
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/009 Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 214.75 42.95 257.7 4% 8.59 223.34 44.67 268.01 16% 25 248.34 49.67 298.01 НСР-3305/24.04.2014; НСР-9708/07.07.2016; НСР-14021/02.10.2017 17.10.2017 02.11.2017 Неактивен 2719
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/010 Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 287.29 57.46 344.75 4% 10 297.29 59.46 356.75 16% 25 322.29 64.46 386.75 НСР-3304/24.04.2014; НСР-9707/07.07.2016 22.07.2016 02.08.2016 Неактивен 2720
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 Mircera, Solution for injection, 50 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 143.5 28.7 172.2 4% 5.74 149.24 29.85 179.09 16% 22.96 172.2 34.44 206.64 НСР-4286/05.08.2014; НСР-10453/29.09.2016 14.10.2016 02.11.2016 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/009 Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 215.47 43.09 258.56 4% 8.62 224.09 44.82 268.91 16% 25 249.09 49.82 298.91 НСР-3305/24.04.2014; НСР-9708/07.07.2016 02.08.2016 02.08.2016 Неактивен 2719
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 430.91 86.18 517.09 4% 10 440.91 88.18 529.09 16% 25 465.91 93.18 559.09 НСР-3302/24.04.2014; НСР-9709/07.07.2016 02.08.2016 02.08.2016 Неактивен 2721
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 Mircera, Solution for injection, 50 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 143.66 28.73 172.39 4% 5.75 149.41 29.88 179.29 16% 22.99 172.4 34.48 206.88 НСР-4286/05.08.2014 20.08.2014 20.08.2014 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/010 Mircera, Solution for injection, 100 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 287.31 57.46 344.77 4% 10 297.31 59.46 356.77 16% 25 322.31 64.46 386.77 НСР-3304/24.04.2014 08.05.2014 08.05.2014 Неактивен 2720
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/009 Mircera, Solution for injection, 75 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 215.49 43.1 258.59 4% 8.62 224.11 44.82 268.93 16% 25 249.11 49.82 298.93 НСР-3305/24.04.2014 08.05.2014 08.05.2014 Неактивен 2719
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 Mircera, Solution for injection, 150 µg/0,3 ml, -, Pack: 1 pre-filled syringe Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 430.95 86.19 517.14 4% 10 440.95 88.19 529.14 16% 25 465.95 93.19 559.14 НСР-3302/24.04.2014 08.05.2014 08.05.2014 Неактивен 2721
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/012 MIRCERA, Solution for injection, 200, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 574.6 114.92 689.52 4% 10 584.6 116.92 701.52 16% 25 609.6 121.92 731.52 цената се заличава с решение НСР-8587/24.03.2016 (в сила от 02.05.2016) НСР-3303/24.04.2014 08.05.2014 08.05.2014 Заличен 2722
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 MIRCERA, Solution for injection, 50, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 156.96 31.39 188.35 4% 6.28 163.24 32.65 195.89 16% 25 188.24 37.65 225.89 НСР-1922/27.11.2013 19.12.2013 19.12.2013 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 MIRCERA, Solution for injection, 150, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 478.83 95.77 574.6 4% 10 488.83 97.77 586.6 16% 25 513.83 102.77 616.6 отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1574/01.11.2013 КЦРР-1185/18.08.2012 04.09.2012 04.09.2012 Неактивен 2721
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/012 MIRCERA, Solution for injection, 200, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 638.44 127.69 766.13 4% 10 648.44 129.69 778.13 16% 25 673.44 134.69 808.13 отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1575/01.11.2013 КЦРР-1185/18.08.2012 04.09.2012 04.09.2012 Неактивен 2722
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/010 MIRCERA, Solution for injection, 100, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 319.23 63.85 383.08 4% 10 329.23 65.85 395.08 16% 25 354.23 70.85 425.08 отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1568/01.11.2013 КЦРР-1185/18.08.2012 04.09.2012 04.09.2012 Неактивен 2720
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/009 MIRCERA, Solution for injection, 75, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 239.43 47.89 287.32 4% 9.58 249.01 49.8 298.81 16% 25 274.01 54.8 328.81 отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1576/01.11.2013 КЦРР-1185/18.08.2012 04.09.2012 04.09.2012 Неактивен 2719
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/008 MIRCERA, Solution for injection, 50, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG, Germany 159.62 31.92 191.54 4% 6.38 166 33.2 199.2 16% 25 191 38.2 229.2 отхвърлена жалба от Комисия по прозрачност с решение КП-191/24.04.2013; промяна на обстоятелства НСР-1578/01.11.2013 КЦРР-1185/18.08.2012 04.09.2012 04.09.2012 Неактивен 3137
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/012 MIRCERA, Solution for injection, 200, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Diagnostics GmbH - Germany 851.72 170.34 1022.06 4% 10 861.72 172.34 1034.06 16% 25 886.72 177.34 1064.06 КЦ-529/13.02.2009 02.03.2009 02.03.2009 Неактивен 2722
Methoxy polyethylene glycol-epoetin beta EU/1/07/400/011 MIRCERA, Solution for injection, 150, mcg/ 0,3ml, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Diagnostics GmbH - Germany 639.01 127.8 766.81 4% 10 649.01 129.8 778.81 16% 25 674.01 134.8 808.81 КЦ-529/13.02.2009 02.03.2009 02.03.2009 Неактивен 2721
Showing 9026 to 9051 of 16676 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте